drugset / Trial / NCT02804386

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

NCT02804386

Phase 4 Completed 573 enrolled PharmEvo Pvt Ltd
NaSingle-groupOpen-labelTreatment

Summary

Title Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin with or without Interferon among Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS) Study Design Endpoint Classification: Safety/Efficacy Study Intervention Model: Treatment agents (non-interventional observational study): Real life clinical practice study Masking: Open Label Primary Purpose: Treatment Duration Around 12 Months Study Centre Multi centric Study

Timeline

Start
2016-06
Primary completion
2017-12-31
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sofosbuvir Small molecule 400 mg Oral